Santen Pharmaceutical Intends to Buy Back and Cancel up to 38 Billion Yen Worth of Shares
Santen Pharmaceutical (TYO:4536) intends to acquire up to 21.11 million shares worth 38 billion yen from May 10 to Nov. 6 through trading on the Tokyo stock exchange (including off-floor trading), acc
Fuji HD, Rinnai, etc. (added) Rating
Upgrade-Bullish Code | Stock Name | Securities Company | Conventional | After Change |------|------------|------------|------------|---------|<9229>|SunWells |Nomura | “Neutral” | “Buy” |<9434>|SoftBank | Germany | “Hold” | “Buy” |Target Stock Price Change Code
Ajinomoto and others announced stock buybacks on 5/9
The stocks that announced their share acquisition quota settings on 5/9 (Thursday) are as follows <2802>Ajinomoto 12.5 million shares (2.4%) 50 billion yen (24/5/10-24/8/30) <4536>Santenyaku 21.11 million shares (5.8%) 38 billion yen (24/5/10-24/11/6) <5021>Cosmoene HD 3.5 million shares (4.0%) 23 billion yen (24/5/10-25/3/31) <8282>ke
SoftBank's 24/3 operating profit down 17.4% to 876 billion yen, 25/3 forecast 2.7% increase to 900 billion yen
The financial results for the fiscal year ending 2024/3 announced by SoftBank <9434> were sales of 6.84 billion yen, up 2.9% from the previous fiscal year, and operating profit of 876 billion 68 billion yen, down 17.4% from the same period. As for the financial results for the fiscal year ending 2025/3, we plan that sales will increase 1.9% from the previous fiscal year to 6.2 trillion yen, and operating profit will increase 2.7% to 900 billion yen. Consumer businesses, etc., including the main mobile, are expected to grow. Sales of terminals will increase, and profit will increase as sales fees decrease.
Santen Pharmaceutical Co., Ltd. Reports FY Results
Express News | Santen Pharmaceutical Co Ltd - to Buy Back up to 5.8% of Shares Worth 38 Bln Yen
Express News | Santen Pharm 2023/24 Group (Ifrs) Net Profit 26.64 Bln Yen Vs Loss 14.95 Bln Yen
Express News | Santen Pharm 2023/24 Group (Ifrs) Pretax Profit 29.87 Bln Yen Vs Loss 5.80 Bln Yen, 2024/25 Forecast Profit 45.00 Bln Yen (+50.6 %)
Santen Pharmaceutical: Financial Results for the Fiscal Year Ending March 31, 2024 [IFRS] (Consolidated)
Kirin HD, Takeda Pharmaceutical, Sumitomo, SoftBank (9th)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/9 (Thu) <1375>Snow Country Maitake <1720>Tokyu Construction<1738>Nittoh <1764>Kudo Construction<1788>Santo Kogyo <1799>Daiichi Kenset<1869>Meikouken <1870>Yahagi Kenset<1929
List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Kumagai Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1820> Nishimatsuken 4543 4488.5 4282 <1860> Todaken 1020 1005.25 988.5 <1861> Kumagai Gumi 4130 4102.5 4010 <1934>
Taisei Corporation, Toa Road Industries, etc. (Part 1)
<1801>Taisei Corporation Mizuho Bank, Ltd. Stock Ownership Ratio 5.35% → 4.33% Reporting Obligation Date 2024/04/15 <1882>Toa Road Industries Co., Ltd. Sumitomo Mitsui DS Asset Management Co., Ltd. Stock Ownership Ratio -% → 5.09% Reporting Obligation Date 2024/04/15 <1926>Light Industries, Ltd. Sumitomo Mitsui DS Asset Management Co., Ltd. Stock Ownership Ratio 7.10% → 6.3
Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]
○ Purchase conversion stock list market code stock name closing price SAR Tokyo Stock Exchange Prime <2053> Chubu Feed 1173 1080 <2109> DM Mitsui Sugar 3025 2937 <2266> Rokko Butter 1453 1395 <2294> Kakiyasu Main Store 3180 3090 <2590> dyDo
Express News | Silchester Owns 5.02% Stake in Santen Pharmaceutical Co - Filing
10th International TFOS Conference on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance Announced
BOSTON, April 11, 2024 /PRNewswire/ -- The Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, has announced the "10th International TFOS Conference on the
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1662> Petroleum Resources 6660 6960 <1726> Br. HD 370 389 <1812> Kashima 3073 3213 <1821> Misumi Kensetsu 420 460 <1870> Yahagi Ken
List of Unrivaled Stocks (Part 2) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Kumo Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1762> Takamatsu G 2771 2784.25 2803.5 <1808> Haseko 1874 1900 1885 <1821> Misumi Kensetsu 420 426 424 <2053> Chubu Feed
Stocks that moved the day before part 1 regional newspapers, TORICO, Omron, etc.
<コード>Stock name 1-day closing price ⇒ Claudia <3607> 445 +22 first half operating income increased 30.2% compared to the previous day. Mitachi <3321> 1143-92 cumulative operating profit for the 3rd quarter decreased by 41.9%. Energy Change <4169> submitted an application for approval to extend the deadline for submitting securities reports for the fiscal year ending 585-10023/12. Regional newspaper company <2164> 631 +10024 turned into an operating surplus in the first half of the fiscal year ending 2014/8. General Medical Research Holdings<2385> 191 +29 East
Front market [stocks that have moved, stocks that have been created]
*Casio Calculator <6952> 1362.5 +66.5 No materials found, leading to buybacks and rising Citizens? *Citizen Watch <7762> 1038 +47 Jeffries Securities upgraded investment decisions. *Strong FA related movements such as Omron <6645> 5666 +255 FANUC and Yaskawa Electric. *Erex <9517> is it a sense of going all out of its way to sell it by hand due to the 724 +31 junction break? *Japan Material <6055> 2516 +107
List of Yunlou stocks [Ichimoku equilibrium table/ Yunlou stock list]
○Kumo Stock List Market Code Stock Name Closing Price Advance Span A Preceding Span B Tokyo Stock Exchange Prime <1808> Haseko 1926 1902 1885 <2288> Marudaishoku 1659 1654.75 1628.5 <2335> Cubesys 1124 1117.5 1105.5 <2502> Asa
No Data